{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:40:49Z","timestamp":1782895249324,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pmr.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:22:53Z","timestamp":1780658573000},"page":"373-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prescriptions with Precision"],"prefix":"10.1016","volume":"37","author":[{"given":"Rebecca","family":"Ovsiowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn Wonders","family":"Convery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pmr.2026.03.002_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.aorn.2014.12.009","article-title":"Multimodal pain management and the future of a personalized medicine approach to pain","volume":"101","author":"Manworren","year":"2015","journal-title":"AORN J"},{"key":"10.1016\/j.pmr.2026.03.002_bib2","series-title":"Practical management of pain","first-page":"183","article-title":"Mechanism-based treatment and precision medicine","author":"Cheng","year":"2023"},{"key":"10.1016\/j.pmr.2026.03.002_bib3","series-title":"H.L., The Massachusetts General Hospital Handbook of Pain Management","first-page":"565","article-title":"Appendix VII: drugs commonly used in pain practice","author":"Black","year":"2005"},{"issue":"6","key":"10.1016\/j.pmr.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s10787-025-01779-x","article-title":"Paracetamol: the potential therapeutic pathways defining its clinical use","volume":"33","author":"Al-Kuraishy","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pmr.2026.03.002_bib6","article-title":"Acetaminophen attenuates pathological pain through a mechanism that requires CB1 cannabinoid receptors and the enzyme diacylglycerol lipase in mice","author":"Jesus","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.pmr.2026.03.002_bib7","article-title":"Acetaminophen inhibits diacylglycerol lipase synthesis of 2-arachidonoyl glycerol: implications for nociception","volume":"6","author":"Dvorakova","year":"2025","journal-title":"Cell Rep Med"},{"issue":"23","key":"10.1016\/j.pmr.2026.03.002_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2413811122","article-title":"The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels","volume":"122","author":"Maatuf","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pmr.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.ajog.2017.01.021","article-title":"Prenatal acetaminophen use and outcomes in children","volume":"216","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.pmr.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41574-021-00553-7","article-title":"Paracetamol use during pregnancy \u2014 a call for precautionary action","volume":"17","author":"Bauer","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pmr.2026.03.002_bib12","unstructured":"Drug Class Overview NSAIDs. In: Elsevier Drug Information; 2025. Available at: https:\/\/www.clinicalkey.com (Accessed 21 March 2025), 2023."},{"key":"10.1016\/j.pmr.2026.03.002_bib13","unstructured":"EC Naprosyn (naproxen delayed-release tablets), Naprosyn (naproxen tablets), Anaprox DS (naproxen sodium tablets) [Package insert]. Canton Laboratories, LLC; 2024."},{"key":"10.1016\/j.pmr.2026.03.002_bib14","series-title":"Aleve (naproxen) [Package Insert]","year":"2022"},{"key":"10.1016\/j.pmr.2026.03.002_bib15","series-title":"Advil Migraine (ibuprofen) capsule [Package insert]","year":"2021"},{"key":"10.1016\/j.pmr.2026.03.002_bib16","series-title":"Elyxyb (celecoxib) [Package Insert]","year":"2020"},{"key":"10.1016\/j.pmr.2026.03.002_bib17","series-title":"Advil (Ibuprofen) [Package Insert]","year":"2023"},{"key":"10.1016\/j.pmr.2026.03.002_bib18","series-title":"Celebrex (celecoxib) [Package insert]","year":"2024"},{"issue":"6","key":"10.1016\/j.pmr.2026.03.002_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pmr.2026.03.002_bib20","unstructured":"Buys, Widenfeld. Osteoarthritis."},{"issue":"2","key":"10.1016\/j.pmr.2026.03.002_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pmr.2020.01.007","article-title":"Opioids: pharmacology, physiology, and clinical implications in pain medicine","volume":"31","author":"Friedman","year":"2020","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.pmr.2026.03.002_bib22","series-title":"Pharmacotherapy: a pathophysiologic approach","article-title":"Pain management","author":"Herndon","year":"2017"},{"issue":"7","key":"10.1016\/j.pmr.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pmr.2026.03.002_bib24","series-title":"DiPiro\u2019s pharmacotherapy handbook","article-title":"Pain management","year":"2023"},{"issue":"3","key":"10.1016\/j.pmr.2026.03.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.pmr.2026.03.002_bib26","author":"Lewin Group","year":"2022"},{"issue":"2","key":"10.1016\/j.pmr.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2049463720912496","article-title":"Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice","volume":"14","author":"Chincholkar","year":"2020","journal-title":"Br J Pain"},{"issue":"3","key":"10.1016\/j.pmr.2026.03.002_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11096-022-01528-y","article-title":"The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials","volume":"45","author":"Meaadi","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.pmr.2026.03.002_bib29","series-title":"LexiDrugs","article-title":"Gabapentin","year":"2024"},{"key":"10.1016\/j.pmr.2026.03.002_bib30","series-title":"Lex-Drugs","article-title":"Pregabalin","year":"2024"},{"issue":"5","key":"10.1016\/j.pmr.2026.03.002_bib31","article-title":"Pregabalin for neuropathic pain in adults","volume":"2019","author":"Derry","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.pmr.2026.03.002_bib32","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"2020","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pmr.2026.03.002_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1009950","article-title":"Risk of major adverse events associated with gabapentinoid and opioid combination therapy: a systematic review and meta-analysis","volume":"13","author":"Hahn","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pmr.2026.03.002_bib34","unstructured":"Amitriptyline. In: Lexi-Drugs. UpToDate Inc; 2024. Available at: http:\/\/online.lexi.com (Accessed 25 March 2025), 2025."},{"key":"10.1016\/j.pmr.2026.03.002_bib36","unstructured":"Venlafaxine. LexiComp."},{"key":"10.1016\/j.pmr.2026.03.002_bib37","unstructured":"Milnacipran. LexiComp."},{"issue":"11","key":"10.1016\/j.pmr.2026.03.002_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112483","article-title":"Analgesic mechanisms of antidepressants for neuropathic pain","volume":"18","author":"Obata","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pmr.2026.03.002_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.JAA.0000512228.23432.f7","article-title":"An update on the pharmacologic management and treatment of neuropathic pain","volume":"30","author":"Wright","year":"2017","journal-title":"JAAPA"},{"issue":"3","key":"10.1016\/j.pmr.2026.03.002_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bpa.2020.08.007","article-title":"The use of antineuropathic medications for the treatment of chronic pain","volume":"34","author":"Urits","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.pmr.2026.03.002_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-9-6","article-title":"Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain","volume":"9","author":"Quilici","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1016\/j.pmr.2026.03.002_bib42","unstructured":"Nortriptyline. LexiComp."},{"key":"10.1016\/j.pmr.2026.03.002_bib43","unstructured":"Desipramine. Lexicomp."},{"issue":"2","key":"10.1016\/j.pmr.2026.03.002_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jps.2600620219","article-title":"Determination of dantrolene in biological specimens containing drug-related metabolites","volume":"62","author":"Hollifield","year":"1973","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pmr.2026.03.002_bib45","unstructured":"Dantrolene. MIcromedex."},{"key":"10.1016\/j.pmr.2026.03.002_bib46","unstructured":"Diazepam - Libervant oral buccal film. package insert."},{"key":"10.1016\/j.pmr.2026.03.002_bib47","unstructured":"Diazepam - Valtoco nasal spray. package insert."},{"key":"10.1016\/j.pmr.2026.03.002_bib48","unstructured":"Diazepam. Micromedex."},{"key":"10.1016\/j.pmr.2026.03.002_bib49","unstructured":"Methocarbamol. Daily Med Package insert."}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104796512600029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104796512600029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:37:05Z","timestamp":1782891425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104796512600029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S104796512600029X"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2026.03.002","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescriptions with Precision","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}